VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3126
ETF rank
ยฃ12.93 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ17.49
Share price
1.34%
Change (1 day)
10.04%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of January 2026: 0.35%